Archive: Sectors

April 7, 2023

GM crops

Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)

Next generation sequencing

Nucleic acid synthesis

Personalised medicine/disease biomarkers

Recombinant protein production and purification

Stem cell therapies

Synthetic biology

Therapeutic antibodies

Vaccinology (e.g. viral vectors; mRNA vaccines)